PMID

Data

Article Title

Organization

Control of hepatitis C: a medicinal chemistry perspective.

University of Wollongong

Anchor-GRIND: filling the gap between standard 3D QSAR and the GRid-INdependent descriptors.

Imim/Universitat Pompeu Fabra

Capped dipeptide phenethylamide inhibitors of the HCV NS3 protease.

Irbm, Mrl Rome

Discovery of thiophene-2-carboxylic acids as potent inhibitors of HCV NS5B polymerase and HCV subgenomic RNA replication. Part 2: tertiary amides.

Shire Biochem

Discovery of thiophene-2-carboxylic acids as potent inhibitors of HCV NS5B polymerase and HCV subgenomic RNA replication. Part 1: Sulfonamides.

Shire Biochem

Further SAR studies on novel small molecule inhibitors of the hepatitis C (HCV) NS5B polymerase.

Shire Biochem

Glycine alpha-ketoamides as HCV NS3 protease inhibitors.

Pharmaceutical Research Institute

Evolution, synthesis and SAR of tripeptide alpha-ketoacid inhibitors of the hepatitis C virus NS3/NS4A serine protease.

Irbm, Mrl Rome

Structural basis of mycobacterial inhibition by cyclomarin A

Novartis Institute For Tropical Diseases

Pre-existent asymmetry in the human cyclooxygenase-2 sequence homodimer.

University of Michigan Medical School

A structure/activity relationship study on arvanil, an endocannabinoid and vanilloid hybrid.

Istituto Di Chimica Biomolecolare

Discovery of a tetrazole-based growth hormone secretagogue: 4-(hydroxybutyl)carbamic acid 2-{5-[1-(2-amino-2-methylpropionylamino)-2- benzyloxyethyl]tetrazol-1-yl}ethyl ester (BMS-317180).

Bristol-Myers Squibb Pharmaceutical Research Institute

Thermal denaturation: a method to rank slow binding, high-affinity P38alpha MAP kinase inhibitors.

Boehringer Ingelheim Pharmaceuticals